Paper34829969
Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges.
Kandimalla R and 7 others. Biomedicines, 2021. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges. Papers, record 34829969. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34829969
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Counting on COVID-19 Vaccine: Insights into the Current Strategies, Progress and Future Challenges.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References216
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 32075877 | Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. | Science | 2020 | https://conductscience.org/library/papers/32075877 | PubMed |
| 2 | 33923530 | Analysis of Thrombotic Adverse Reactions of COVID-19 AstraZeneca Vaccine Reported to EudraVigilance Database. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/33923530 | PubMed |
| 3 | 33883164 | Covid-19: Unusual blood clots are "very rare side effect" of Janssen vaccine, says EMA. | BMJ | 2021 | https://conductscience.org/library/papers/33883164 | PubMed |
| 4 | 33956782 | Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021. | MMWR Morb Mortal Wkly Rep | 2021 | https://conductscience.org/library/papers/33956782 | PubMed |
| 5 | 33935343 | Sputnik V vaccine goes global. | New Sci | 2021 | https://conductscience.org/library/papers/33935343 | PubMed |
| 6 | 34190859 | CoronaVac can induce the production of anti-SARS-CoV-2 IgA antibodies in human milk. | Clinics (Sao Paulo) | 2021 | https://conductscience.org/library/papers/34190859 | PubMed |
| 7 | 32789505 | Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials. | JAMA | 2020 | https://conductscience.org/library/papers/32789505 | PubMed |
| 8 | 33479399 | COVID-19 vaccines: where we stand and challenges ahead. | Cell Death Differ | 2021 | https://conductscience.org/library/papers/33479399 | PubMed |
| 9 | 34358154 | Humoral Response to SARS-Cov-2 Vaccination in Liver Transplant Recipients-A Single-Center Experience. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34358154 | PubMed |
| 10 | 33460347 | SARS-CoV-2 Vaccines: Much Accomplished, Much to Learn. | Ann Intern Med | 2021 | https://conductscience.org/library/papers/33460347 | PubMed |
| 11 | 34358195 | Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants. | Vaccines (Basel) | 2021 | https://conductscience.org/library/papers/34358195 | PubMed |
| 12 | 32722908 | Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates. | N Engl J Med | 2020 | https://conductscience.org/library/papers/32722908 | PubMed |
| 13 | 32231345 | Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion. | Cell Res | 2020 | https://conductscience.org/library/papers/32231345 | PubMed |
| 14 | 33306989 | Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. | Lancet | 2021 | https://conductscience.org/library/papers/33306989 | PubMed |
| 15 | 34099338 | Breakthrough COVID-19 case after full-dose administration of CoronaVac vaccine. | Indian J Med Microbiol | 2021 | https://conductscience.org/library/papers/34099338 | PubMed |
| 16 | 32800805 | COVID-19 Vaccine: A comprehensive status report. | Virus Res | 2020 | https://conductscience.org/library/papers/32800805 | PubMed |
| 17 | 34161817 | Waning antibodies in SARS-CoV-2 naïve vaccinees: Results of a three-month interim analysis of ongoing immunogenicity and efficacy surveillance of the mRNA-1273 vaccine in healthcare workers. | J Infect | 2021 | https://conductscience.org/library/papers/34161817 | PubMed |
| 18 | 34206727 | Case Study of Two Post Vaccination SARS-CoV-2 Infections with P1 Variants in CoronaVac Vaccinees in Brazil. | Viruses | 2021 | https://conductscience.org/library/papers/34206727 | PubMed |
| 19 | 34222133 | Acute myocarditis associated with anti-COVID-19 vaccination. | Clin Exp Vaccine Res | 2021 | https://conductscience.org/library/papers/34222133 | PubMed |
| 20 | 32645974 | SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings. | Pathogens | 2020 | https://conductscience.org/library/papers/32645974 | PubMed |
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 37784095 | Investigating the tendency to use COVID-19 vaccine booster dose in Iran. | BMC Health Serv Res | 2023 | https://conductscience.org/library/papers/37784095 | PubMed |
| 37376684 | The Pathogenesis of Cytomegalovirus and Other Viruses Associated with Hearing Loss: Recent Updates. | Viruses | 2023 | https://conductscience.org/library/papers/37376684 | PubMed |
| 37261578 | Pathways to Immunity: Patterns of Excess Death Across the United States and Within Closed Religious Communities. | J Relig Health | 2023 | https://conductscience.org/library/papers/37261578 | PubMed |
| 36844687 | Exploring the experience of developing COVID-19 vaccines in Iran. | Clin Exp Vaccine Res | 2023 | https://conductscience.org/library/papers/36844687 | PubMed |
| 36528447 | Cold-adapted SARS-CoV-2 variants with different temperature sensitivity exhibit an attenuated phenotype and confer protective immunity. | Vaccine | 2023 | https://conductscience.org/library/papers/36528447 | PubMed |
| 36479305 | Understanding the Attitudes and Willingness of Adult Chinese Patients with Rheumatic Diseases Towards COVID-19 Vaccination. | Risk Manag Healthc Policy | 2022 | https://conductscience.org/library/papers/36479305 | PubMed |
| 36430684 | Molecular Mechanisms of Pathogenesis, Prevention, and Therapy of COVID-19: Summarizing the Results of 2021. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36430684 | PubMed |
| 36381644 | COVID-19 and its genomic variants: Molecular pathogenesis and therapeutic interventions. | EXCLI J | 2022 | https://conductscience.org/library/papers/36381644 | PubMed |
| 36298563 | Immunization with a Prefusion SARS-CoV-2 Spike Protein Vaccine (RBMRNA-176) Protects against Viral Challenge in Mice and Nonhuman Primates. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/36298563 | PubMed |
| 35910658 | A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19. | Front Microbiol | 2022 | https://conductscience.org/library/papers/35910658 | PubMed |
| 35857146 | Immunogenic properties of SARS-CoV-2 inactivated by ultraviolet light. | Arch Virol | 2022 | https://conductscience.org/library/papers/35857146 | PubMed |
| 35740269 | Thrombotic Complications after COVID-19 Vaccination: Diagnosis and Treatment Options. | Biomedicines | 2022 | https://conductscience.org/library/papers/35740269 | PubMed |
| 35458489 | Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena. | Viruses | 2022 | https://conductscience.org/library/papers/35458489 | PubMed |
| 35277864 | SARS-CoV-2 variants and vulnerability at the global level. | J Med Virol | 2022 | https://conductscience.org/library/papers/35277864 | PubMed |
| 35267980 | Healthy Immunity on Preventive Medicine for Combating COVID-19. | Nutrients | 2022 | https://conductscience.org/library/papers/35267980 | PubMed |
| 35214652 | Comparing SARS-CoV-2 Antibody Responses after Various COVID-19 Vaccinations in Healthcare Workers. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/35214652 | PubMed |
| 35065135 | Review: A systematic review of virus-like particles of coronavirus: Assembly, generation, chimerism and their application in basic research and in the clinic. | Int J Biol Macromol | 2022 | https://conductscience.org/library/papers/35065135 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34829969
GET https://conductscience.org/api/papers/v1/34829969/references?page=2